Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain.

Younger J, Parkitny L, McLain D.

Clin Rheumatol. 2014 Apr;33(4):451-9. doi: 10.1007/s10067-014-2517-2. Epub 2014 Feb 15. Review.

3.

Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study.

Younger J, Mackey S.

Pain Med. 2009 May-Jun;10(4):663-72. doi: 10.1111/j.1526-4637.2009.00613.x. Epub 2009 Apr 22.

4.

Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis.

Zagon IS, Rahn KA, Turel AP, McLaughlin PJ.

Exp Biol Med (Maywood). 2009 Nov;234(11):1383-92. doi: 10.3181/0906-RM-189.

PMID:
19855075
5.
6.

Low-dose naltrexone and opioid consumption: a drug utilization cohort study based on data from the Norwegian prescription database.

Raknes G, Småbrekke L.

Pharmacoepidemiol Drug Saf. 2017 Jun;26(6):685-693. doi: 10.1002/pds.4201. Epub 2017 Mar 29.

PMID:
28370746
7.

Reduced Pro-Inflammatory Cytokines after Eight Weeks of Low-Dose Naltrexone for Fibromyalgia.

Parkitny L, Younger J.

Biomedicines. 2017 Apr 18;5(2). pii: E16. doi: 10.3390/biomedicines5020016.

8.

Low-dose naltrexone therapy improves active Crohn's disease.

Smith JP, Stock H, Bingaman S, Mauger D, Rogosnitzky M, Zagon IS.

Am J Gastroenterol. 2007 Apr;102(4):820-8. Epub 2007 Jan 11.

PMID:
17222320
9.

Treatment of Complex Regional Pain Syndrome (CRPS) using low dose naltrexone (LDN).

Chopra P, Cooper MS.

J Neuroimmune Pharmacol. 2013 Jun;8(3):470-6. doi: 10.1007/s11481-013-9451-y. Epub 2013 Apr 2.

10.

The Use of Naltrexone in Low Doses Beyond the Approved Indication [Internet].

Ringerike T, Pike E, Nevjar J, Klemp M.

Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2015 Apr.

11.

The use of opioids in fibromyalgia.

Ngian GS, Guymer EK, Littlejohn GO.

Int J Rheum Dis. 2011 Feb;14(1):6-11. doi: 10.1111/j.1756-185X.2010.01567.x. Epub 2010 Aug 23. Review.

PMID:
21303476
12.

Low dose naltrexone (LDN) enhances maturation of bone marrow dendritic cells (BMDCs).

Meng J, Meng Y, Plotnikoff NP, Youkilis G, Griffin N, Shan F.

Int Immunopharmacol. 2013 Dec;17(4):1084-9.

PMID:
24455776
13.

The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.

Pettinati HM, O'Brien CP, Rabinowitz AR, Wortman SP, Oslin DW, Kampman KM, Dackis CA.

J Clin Psychopharmacol. 2006 Dec;26(6):610-25. Review.

PMID:
17110818
14.

[Low dose naltrexone for treatment of pain].

Plesner KB, Vægter HB, Handberg G.

Ugeskr Laeger. 2015 Oct 9;177(43):V03150248. Danish.

PMID:
26509454
15.

Functional modulation on macrophage by low dose naltrexone (LDN).

Yi Z, Guo S, Hu X, Wang X, Zhang X, Griffin N, Shan F.

Int Immunopharmacol. 2016 Oct;39:397-402. doi: 10.1016/j.intimp.2016.08.015. Epub 2016 Aug 23.

PMID:
27561742
16.

Fibromyalgia syndrome--novel therapeutic targets.

Ablin JN, Buskila D.

Maturitas. 2013 Aug;75(4):335-40. doi: 10.1016/j.maturitas.2013.05.004. Epub 2013 Jun 3. Review.

PMID:
23742873
17.

Naltrexone at low doses upregulates a unique gene expression not seen with normal doses: Implications for its use in cancer therapy.

Liu WM, Scott KA, Dennis JL, Kaminska E, Levett AJ, Dalgleish AG.

Int J Oncol. 2016 Aug;49(2):793-802. doi: 10.3892/ijo.2016.3567. Epub 2016 Jun 7.

PMID:
27279602
18.

A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain.

Pergolizzi JV Jr, Raffa RB, Taylor R Jr, Rodriguez G, Nalamachu S, Langley P.

Pain Pract. 2013 Mar;13(3):239-52. doi: 10.1111/j.1533-2500.2012.00578.x. Epub 2012 Jun 21. Review.

PMID:
22716295
19.

A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis.

Gironi M, Martinelli-Boneschi F, Sacerdote P, Solaro C, Zaffaroni M, Cavarretta R, Moiola L, Bucello S, Radaelli M, Pilato V, Rodegher M, Cursi M, Franchi S, Martinelli V, Nemni R, Comi G, Martino G.

Mult Scler. 2008 Sep;14(8):1076-83. doi: 10.1177/1352458508095828.

PMID:
18728058

Supplemental Content

Support Center